heart device firm gets fda warning cardiology device maker edwards lifesciences corp said it has received a warning letter from the food and drug administration relating to company quality systems at its irvine calif facility the warning letter stems from an inspection that concluded in august and said issues involve complaint handling documentation and quality systems handling the letter states that edwards wont receive fda approval for devices "reasonably related" to the issues at hand until they are resolved the company said still edwards indicated it expects to resolve the warning letter this year without blocking the path for key products fda product decisions on the horizon include a new use for edwards"lifestent " edwards expects approval this year the company still aims for fda approval of another product a next generation replacement valve for the hearts mitral position in the third quarter of this year 
